Mario Forcione1,2, Kamal Makram Yakoub1, Antonio Maria Chiarelli3, David Perpetuini3, Arcangelo Merla3, Rosa Sun1, Piotr Sawosz4, Antonio Belli1,2, David James Davies1,2. 1. University Hospitals Birmingham NHS Foundation Trust, National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR-SRMRC), Mindelsohn Way, Birmingham, UK. 2. University of Birmingham, Neuroscience & Ophthalmology Research Group, Institute of Inflammation & Ageing, College of Medical and Dental Sciences, Edgbaston, Birmingham, UK. 3. University G. D'Annunzio of Chieti-Pescara, Institute for Advanced Biomedical Technologies, Department of Neuroscience, Imaging and Clinical Sciences, Chieti, Italy. 4. Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Trojdena 4, Warsaw, Poland.
Abstract
BACKGROUND: The care given to moderate and severe traumatic brain injury (TBI) patients may be hampered by the inability to tailor their treatments according to their neurological status. Contrast-enhanced near-infrared spectroscopy (NIRS) with indocyanine green (ICG) could be a suitable neuromonitoring tool. METHODS: Monitoring the effective attenuation coefficients (EAC), we compared the ICG kinetics between five TBI and five extracranial trauma patients, following a venous-injection of 5 mL of 1 mg/mL ICG, using two commercially available NIRS devices. RESULTS: A significantly slower passage of the dye through the brain of the TBI group was observed in two parameters related to the first ICG inflow into the brain (P=0.04; P=0.01). This is likely related to the reduction of cerebral perfusion following TBI. Significant changes in ICG optical properties minutes after injection (P=0.04) were registered. The acquisition of valid optical data in a clinical environment was challenging. CONCLUSIONS: Future research should analyze abnormalities in the ICG kinetic following brain trauma, test how these values can enhance care in TBI, and adapt the current optical devices to clinical settings. Also, studies on the pattern in changes of ICG optical properties after venous injection can improve the accuracy of the values detected. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: The care given to moderate and severe traumatic brain injury (TBI) patients may be hampered by the inability to tailor their treatments according to their neurological status. Contrast-enhanced near-infrared spectroscopy (NIRS) with indocyanine green (ICG) could be a suitable neuromonitoring tool. METHODS: Monitoring the effective attenuation coefficients (EAC), we compared the ICG kinetics between five TBI and five extracranial trauma patients, following a venous-injection of 5 mL of 1 mg/mL ICG, using two commercially available NIRS devices. RESULTS: A significantly slower passage of the dye through the brain of the TBI group was observed in two parameters related to the first ICG inflow into the brain (P=0.04; P=0.01). This is likely related to the reduction of cerebral perfusion following TBI. Significant changes in ICG optical properties minutes after injection (P=0.04) were registered. The acquisition of valid optical data in a clinical environment was challenging. CONCLUSIONS: Future research should analyze abnormalities in the ICG kinetic following brain trauma, test how these values can enhance care in TBI, and adapt the current optical devices to clinical settings. Also, studies on the pattern in changes of ICG optical properties after venous injection can improve the accuracy of the values detected. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Authors: Randall M Chesnut; Nancy Temkin; Nancy Carney; Sureyya Dikmen; Carlos Rondina; Walter Videtta; Gustavo Petroni; Silvia Lujan; Jim Pridgeon; Jason Barber; Joan Machamer; Kelley Chaddock; Juanita M Celix; Marianna Cherner; Terence Hendrix Journal: N Engl J Med Date: 2012-12-12 Impact factor: 91.245
Authors: A Liebert; H Wabnitz; J Steinbrink; M Möller; R Macdonald; H Rinneberg; A Villringer; H Obrig Journal: Neuroimage Date: 2004-11-24 Impact factor: 6.556
Authors: David J Davies; Zhangjie Su; Michael T Clancy; Samuel J E Lucas; Hamid Dehghani; Ann Logan; Antonio Belli Journal: J Neurotrauma Date: 2015-04-17 Impact factor: 5.269
Authors: M Hope-Ross; L A Yannuzzi; E S Gragoudas; D R Guyer; J S Slakter; J A Sorenson; S Krupsky; D A Orlock; C A Puliafito Journal: Ophthalmology Date: 1994-03 Impact factor: 12.079
Authors: Xiao Shu; Lisa Beckmann; Yuanbo Wang; Ian Rubinoff; Katie Lucy; Hiroshi Ishikawa; Gadi Wollstein; Amani A Fawzi; Joel S Schuman; Roman V Kuranov; Hao F Zhang Journal: Quant Imaging Med Surg Date: 2019-05
Authors: Mario Ganau; Nikolaos Syrmos; Marco Paris; Laura Ganau; Gianfranco K I Ligarotti; Ali Moghaddamjou; Salvatore Chibbaro; Andrea Soddu; Rossano Ambu; Lara Prisco Journal: Medicines (Basel) Date: 2018-02-05
Authors: Mario Forcione; Mario Ganau; Lara Prisco; Antonio Maria Chiarelli; Andrea Bellelli; Antonio Belli; David James Davies Journal: Int J Mol Sci Date: 2021-01-23 Impact factor: 5.923